Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Cognitive Dysfunction × Patient Reported Outcome Measures × 1 year × Clear all

Sponsor

Conditions

Neoplasms 3 Preleukemia 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Precancerous Conditions 2 Neoplasms by Histologic Type 2 Myelodysplastic Syndromes 2 Lymphoproliferative Disorders 2 Lymphoma 2 Lymphatic Diseases 2 Leukemia, Myeloid, Acute 2 Leukemia, Myeloid 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Lymphoid 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Biphenotypic, Acute 2 Leukemia, B-Cell 2 Leukemia 2 Immunoproliferative Disorders 2 Immune System Diseases 2 Hematologic Diseases 2 Esophageal Neoplasms 2 Breast Neoplasms 2 Bone Marrow Diseases 2 Primary Myelofibrosis 1 Neoplasms, Second Primary 1 Myeloproliferative Disorders 1 Leukemia, Prolymphocytic 1 Leukemia, Myelomonocytic, Chronic 1 Hyperthermia 1 Congenital Abnormalities 1

Interventions

Transcranial Direct Current Stimulation 3 Memantine 2 mazdutide 1 lime 1 enzalutamide 1 Time 1 Standard of Care 1 Ramipril 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Prednisone 1 Population Groups 1 Palliative Care 1 Organization and Administration 1 Methods 1 Low-Level Light Therapy 1 Infliximab 1 Hormones 1 Gonadotropin-Releasing Hormone 1 Exercise 1 Electroencephalography 1 Drug Therapy 1 Drug Delivery Systems 1 Data Collection 1 Cognitive Behavioral Therapy 1 Chemoradiotherapy 1 Anesthesia, General 1 Abiraterone Acetate 1 7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡